Radiation Therapy Shrinks Lymph-Node Tumors in 75% of Advanced Liver Cancer Cases
When hepatocellular carcinoma spreads to the lymph nodes, it is classified as advanced liver cancer, typically requiring systemic treatment such as...
Search results for "immunotherapy"
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors
Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.
Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy
Muscle mass in lung cancer patients may play a decisive role in determining the success of immunotherapy.
Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds
Hearing a doctor say that “the cancer has invaded the portal vein” can be deeply overwhelming for patients with liver...
Stomach Cancer Immunotherapy: Different Effects on Men and Women... Effective for Men, but 'Not So Much' for Women
A study has revealed that the therapeutic effects of 'immune checkpoint inhibitors ', which are gaining attention as...
‘Remarkable AI’ Finds Lung Cancer Patients Who Respond Well to Immunotherapy
A domestic study has revealed that artificial intelligence can preemptively identify lung cancer patients who can...
Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care
“Lately, I keep forgetting appointments.” “They keep repeating what they just said.” When memory lapses in a parent...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’
The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood
Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T)...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...